Prestige Consumer Healthcare Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 12.20%

Prestige Consumer Healthcare Inc. Return on Equity (ROE) is 12.20% for the Trailing 12 Months (TTM) ending March 31, 2025, a -8.62% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Prestige Consumer Healthcare Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 13.35%, a -357.04% change year over year.
  • Prestige Consumer Healthcare Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was -5.19%, a -137.77% change year over year.
  • Prestige Consumer Healthcare Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 13.75%, a 8.28% change year over year.
  • Prestige Consumer Healthcare Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 12.70%, a 1.35% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share